http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014105177-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_71bd6ca6dc921899dfdcc681ce9d2f70 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-341 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 |
| filingDate | 2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0310535f3e3455c5d96462fbf1a7e785 |
| publicationDate | 2014-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014105177-A |
| titleOfInvention | PHARMACEUTICAL COMPOSITION FOR DIABETES TREATMENT AND METHOD OF SCREENING THE ACTIVE INGREDIENT |
| abstract | An object of the present invention is to provide a pharmaceutical composition for the treatment of diabetes comprising a substance capable of suppressing gluconeogenesis in the liver as an active ingredient. Another object of the present invention is to provide a simple screening system for obtaining an active ingredient of the pharmaceutical composition, and further to provide a pharmaceutical composition for treating diabetes containing a substance obtained by the screening system. An object of the present invention is to provide diabetes, hyperthyroidism, pituitary function, which contains as an active ingredient a substance that suppresses activation of gluconeogenic enzyme by K (lysine) acetyltransferase 2A (KAT2A). It can be solved by a pharmaceutical composition for prevention or treatment of a disease accompanied by an increase in blood glucose level selected from hypertension, hyperadrenocorticism, and obesity. [Selection] Figure 1 |
| priorityDate | 2012-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 193.